Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

Market Cap	11.65B -1.8%
Revenue (ttm)	5.22B +0.8%
Net Income	651.95M +5.2%
EPS	0.73 +4.5%
Shares Out	881.71M
PE Ratio	18.10
Forward PE	11.80
Dividend	0.50 (3.70%)
Ex-Dividend Date	Sep 8, 2025

Volume	5,883,458
Average Volume	18,629,694
Open	13.15
Previous Close	13.21
Day's Range	12.96 - 13.22
52-Week Range	12.70 - 22.25
Beta	0.30
RSI	30.73
Earnings Date	Apr 24, 2026

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizho...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1973
• Employees: 4,791
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603456

Financial Performance

In 2025, SHA:603456's revenue was 5.51 billion, an increase of 6.74% compared to the previous year's 5.16 billion. Earnings were 730.07 million, an increase of 20.46%.